000872767 001__ 872767
000872767 005__ 20210130004303.0
000872767 0247_ $$2doi$$a10.1039/C8CS00034D
000872767 0247_ $$2ISSN$$a0306-0012
000872767 0247_ $$2ISSN$$a1460-4744
000872767 0247_ $$2altmetric$$aaltmetric:62509571
000872767 0247_ $$2pmid$$apmid:31192324
000872767 0247_ $$2WOS$$aWOS:000475647600006
000872767 037__ $$aFZJ-2020-00245
000872767 082__ $$a540
000872767 1001_ $$00000-0001-9076-7114$$aOwen, Michael C.$$b0
000872767 245__ $$aEffects of in vivo conditions on amyloid aggregation
000872767 260__ $$aLondon$$bSoc.$$c2019
000872767 3367_ $$2DRIVER$$aarticle
000872767 3367_ $$2DataCite$$aOutput Types/Journal article
000872767 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1580896971_10825
000872767 3367_ $$2BibTeX$$aARTICLE
000872767 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000872767 3367_ $$00$$2EndNote$$aJournal Article
000872767 520__ $$aOne of the grand challenges of biophysical chemistry is to understand the principles that govern protein misfolding and aggregation, which is a highly complex process that is sensitive to initial conditions, operates on a huge range of length- and timescales, and has products that range from protein dimers to macroscopic amyloid fibrils. Aberrant aggregation is associated with more than 25 diseases, which include Alzheimer's, Parkinson's, Huntington's, and type II diabetes. Amyloid aggregation has been extensively studied in the test tube, therefore under conditions that are far from physiological relevance. Hence, there is dire need to extend these investigations to in vivo conditions where amyloid formation is affected by a myriad of biochemical interactions. As a hallmark of neurodegenerative diseases, these interactions need to be understood in detail to develop novel therapeutic interventions, as millions of people globally suffer from neurodegenerative disorders and type II diabetes. The aim of this review is to document the progress in the research on amyloid formation from a physicochemical perspective with a special focus on the physiological factors influencing the aggregation of the amyloid-β peptide, the islet amyloid polypeptide, α-synuclein, and the hungingtin protein.
000872767 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000872767 588__ $$aDataset connected to CrossRef
000872767 7001_ $$00000-0001-9393-503X$$aGnutt, David$$b1
000872767 7001_ $$0P:(DE-HGF)0$$aGao, Mimi$$b2
000872767 7001_ $$0P:(DE-HGF)0$$aWärmländer, Sebastian K. T. S.$$b3
000872767 7001_ $$00000-0002-7863-1887$$aJarvet, Jüri$$b4
000872767 7001_ $$00000-0003-2187-1537$$aGräslund, Astrid$$b5
000872767 7001_ $$00000-0002-3512-6928$$aWinter, Roland$$b6
000872767 7001_ $$00000-0001-9309-1279$$aEbbinghaus, Simon$$b7
000872767 7001_ $$0P:(DE-Juel1)132024$$aStrodel, Birgit$$b8$$eCorresponding author
000872767 773__ $$0PERI:(DE-600)1472875-8$$a10.1039/C8CS00034D$$gVol. 48, no. 14, p. 3946 - 3996$$n14$$p3946 - 3996$$tChemical Society reviews$$v48$$x1460-4744$$y2019
000872767 8564_ $$uhttps://juser.fz-juelich.de/record/872767/files/c8cs00034d.pdf$$yRestricted
000872767 8564_ $$uhttps://juser.fz-juelich.de/record/872767/files/c8cs00034d.pdf?subformat=pdfa$$xpdfa$$yRestricted
000872767 909CO $$ooai:juser.fz-juelich.de:872767$$pVDB
000872767 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132024$$aForschungszentrum Jülich$$b8$$kFZJ
000872767 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000872767 9141_ $$y2019
000872767 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000872767 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000872767 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium
000872767 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCHEM SOC REV : 2017
000872767 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000872767 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000872767 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000872767 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000872767 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000872767 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000872767 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000872767 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000872767 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000872767 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences
000872767 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000872767 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings
000872767 915__ $$0StatID:(DE-HGF)9940$$2StatID$$aIF >= 40$$bCHEM SOC REV : 2017
000872767 920__ $$lyes
000872767 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie$$x0
000872767 980__ $$ajournal
000872767 980__ $$aVDB
000872767 980__ $$aI:(DE-Juel1)ICS-6-20110106
000872767 980__ $$aUNRESTRICTED
000872767 981__ $$aI:(DE-Juel1)IBI-7-20200312